BC Week In Review | Jun 22, 2015
Financial News

Tobira withdraws IPO

Tobira Therapeutics Inc. (NASDAQ:TBRA), San Francisco, Calif.   Business: Infectious, Hepatic   Date announced: 2015-06-15   Type: IPO   Underwriter: Oppenheimer   Note: Tobira withdrew its proposed IPO on NASDAQ. Last month, Tobira merged with...
BC Extra | Jun 16, 2015
Company News

Management tracks

The Biotechnology Industry Organization (BIO) elected Ron Cohen chair of its board of directors and chair of its health section governing board. Cohen, the president and CEO of Acorda Therapeutics Inc. (NASDAQ:ACOR), previously served as...
BC Week In Review | May 11, 2015
Financial News

Tobira completes private placement

Tobira Therapeutics Inc. (NASDAQ:TBRA), San Francisco, Calif.   Business: Infectious, Hepatic   Date completed: 2015-05-04   Type: Private placement   Raised: $23 million   Shares after offering: 17.4 million   Investors: Existing investors; new investors...
BC Week In Review | May 11, 2015
Company News

Regado Biosciences, Tobira deal

Tobira completed its acquisition of Regado. Tobira raised $23 million upon closing of the reverse merger. Regado Biosciences Inc. , Basking Ridge, N.J.   Tobira Therapeutics Inc. (NASDAQ:TBRA), San Francisco, Calif.   Business: Hepatic  ...
BioCentury | Feb 2, 2015
Politics, Policy & Law

Dr. Califf goes to Washington

FDA has had three deputy commissioners during the Obama administration ; each was expected to play a major role in shaping the agency, and none of them lived up to expectations. Last week's announcement that...
BC Extra | Jan 27, 2015
Top Story

FDA names Duke's Califf as deputy commissioner

FDA named Robert Califf as deputy commissioner for medical products and tobacco, positioning the Duke University physician as a likely successor to Commissioner Margaret Hamburg if she steps down before the end of the Obama...
BC Week In Review | Jan 19, 2015
Company News

Regado Biosciences, Tobira deal

Tobira will acquire Regado through a reverse merger in a deal slated to close next quarter. The combined company, which will be named Tobira Therapeutics Inc., plans to develop treatments for liver and inflammatory diseases,...
BC Extra | Jan 15, 2015
Company News

Tobira finds its public path

Tobira Therapeutics Inc. (San Francisco, Calif.) will acquire Regado Biosciences Inc. (NASDAQ:RGDO) through a reverse merger. The combined company, which will be named Tobira Therapeutics and continue to trade on NASDAQ, plans to develop treatments...
BC Week In Review | Jan 12, 2015
Company News

NeoStem management update

NeoStem Inc. (NASDAQ:NBS), New York, N.Y.   Business: Gene/Cell therapy, Supply/Service   Hired: David Mazzo as CEO and a director, formerly CEO and a director of Regado Biosciences Inc. , he succeeds Robin Smith, who remains...
BC Week In Review | Oct 27, 2014
Company News

Regado Biosciences management update

Regado Biosciences Inc. (NASDAQ:RGDO), Basking Ridge, N.J.   Business: Cardiovascular   Transitioned: Michael Metzger to CEO and a director from president and COO; he succeeds David Mazzo, who resigned  ...
Items per page:
1 - 10 of 92
BC Week In Review | Jun 22, 2015
Financial News

Tobira withdraws IPO

Tobira Therapeutics Inc. (NASDAQ:TBRA), San Francisco, Calif.   Business: Infectious, Hepatic   Date announced: 2015-06-15   Type: IPO   Underwriter: Oppenheimer   Note: Tobira withdrew its proposed IPO on NASDAQ. Last month, Tobira merged with...
BC Extra | Jun 16, 2015
Company News

Management tracks

The Biotechnology Industry Organization (BIO) elected Ron Cohen chair of its board of directors and chair of its health section governing board. Cohen, the president and CEO of Acorda Therapeutics Inc. (NASDAQ:ACOR), previously served as...
BC Week In Review | May 11, 2015
Financial News

Tobira completes private placement

Tobira Therapeutics Inc. (NASDAQ:TBRA), San Francisco, Calif.   Business: Infectious, Hepatic   Date completed: 2015-05-04   Type: Private placement   Raised: $23 million   Shares after offering: 17.4 million   Investors: Existing investors; new investors...
BC Week In Review | May 11, 2015
Company News

Regado Biosciences, Tobira deal

Tobira completed its acquisition of Regado. Tobira raised $23 million upon closing of the reverse merger. Regado Biosciences Inc. , Basking Ridge, N.J.   Tobira Therapeutics Inc. (NASDAQ:TBRA), San Francisco, Calif.   Business: Hepatic  ...
BioCentury | Feb 2, 2015
Politics, Policy & Law

Dr. Califf goes to Washington

FDA has had three deputy commissioners during the Obama administration ; each was expected to play a major role in shaping the agency, and none of them lived up to expectations. Last week's announcement that...
BC Extra | Jan 27, 2015
Top Story

FDA names Duke's Califf as deputy commissioner

FDA named Robert Califf as deputy commissioner for medical products and tobacco, positioning the Duke University physician as a likely successor to Commissioner Margaret Hamburg if she steps down before the end of the Obama...
BC Week In Review | Jan 19, 2015
Company News

Regado Biosciences, Tobira deal

Tobira will acquire Regado through a reverse merger in a deal slated to close next quarter. The combined company, which will be named Tobira Therapeutics Inc., plans to develop treatments for liver and inflammatory diseases,...
BC Extra | Jan 15, 2015
Company News

Tobira finds its public path

Tobira Therapeutics Inc. (San Francisco, Calif.) will acquire Regado Biosciences Inc. (NASDAQ:RGDO) through a reverse merger. The combined company, which will be named Tobira Therapeutics and continue to trade on NASDAQ, plans to develop treatments...
BC Week In Review | Jan 12, 2015
Company News

NeoStem management update

NeoStem Inc. (NASDAQ:NBS), New York, N.Y.   Business: Gene/Cell therapy, Supply/Service   Hired: David Mazzo as CEO and a director, formerly CEO and a director of Regado Biosciences Inc. , he succeeds Robin Smith, who remains...
BC Week In Review | Oct 27, 2014
Company News

Regado Biosciences management update

Regado Biosciences Inc. (NASDAQ:RGDO), Basking Ridge, N.J.   Business: Cardiovascular   Transitioned: Michael Metzger to CEO and a director from president and COO; he succeeds David Mazzo, who resigned  ...
Items per page:
1 - 10 of 92